Herein, we demonstrated that metformin can improve intestinal mucosal barrier function by affecting the expression of tight junction proteins in the intestinal mucosa, including occludin, ZO-1, and claudins, which are closely related to the development of CRC. Here, OCLN is linked to colorectal carcinoma.